Clinical Trials Sponsored by Maxygen ApS

Total 1184 results

AHS Cancer Control Alberta

Unknown

Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating

Carcinoma, Non-Small-Cell Lung

Canada
AHS Cancer Control Alberta

Completed

Aerobic Capacity and Body Composition in Colon Cancer Patients

Colonic Neoplasms

Canada
AHS Cancer Control Alberta

Terminated

Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins

Colorectal Cancer | Lung Cancer

Canada
AHS Cancer Control Alberta

Completed

Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix Cancer

Cervix Cancer

Canada
AHS Cancer Control Alberta

Completed

Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function

Head and Neck Cancer

Canada
AHS Cancer Control Alberta

Withdrawn

Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma

Glioblastoma
AHS Cancer Control Alberta

Unknown

Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer

Pancreas Cancer

Canada
AHS Cancer Control Alberta

Unknown

Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer

Small Cell Lung Cancer

Canada
AHS Cancer Control Alberta

Unknown

A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer (Panc001)

Metastatic Pancreas Cancer

Canada
AHS Cancer Control Alberta

Terminated

Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection

Breast Neoplasms

Canada
University of Copenhagen
Movesca ApS; Departmen for rehabilitation M3, Hobro Hospital

Completed

Intervention of Diet Registration Method for Rehabilitation Patients

Digital Clinical Diet Registrations Advantages | Patients in Rehabilitation

Denmark
Organon and Co
Institute for Applied Economics and Health Research Aps

Completed

Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021).

Male Breast Cancer
Dennis Bregner Zetner
Herlev Hospital; Copenhagen University Hospital, Denmark; RepoCeuticals ApS

Completed

Pharmacokinetics of Intravenous, Rectal, Intravesical, Vaginal, and Transdermal Melatonin in Healthy Female Volunteers

Pharmacokinetics | Safety | Melatonin

Denmark
AHS Cancer Control Alberta

Not yet recruiting

PET/MRI in Rectal Cancer

Rectal Cancer
AHS Cancer Control Alberta

Not yet recruiting

SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases

Colorectal Cancer | Liver Metastasis Colon Cancer

Canada
Tesu Saglik Teknolojileri A.S.

Recruiting

Efficacy and Safety of Digital Therapeutic in Adults With Prediabetes

PreDiabetes

Turkey
AHS Cancer Control Alberta

Not yet recruiting

BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma (BIOSELECT)

Mycosis Fungoides

Canada
AHS Cancer Control Alberta

Recruiting

Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)

Cancer

Canada
AHS Cancer Control Alberta

Not yet recruiting

High Heated Humidity in Stem Cell Transplant

Autologous Stem Cell Transplant

Canada
AHS Cancer Control Alberta

Not yet recruiting

Steroid Sparing in Immune Related Hepatitis (irH)

Hepatitis Immune
AHS Cancer Control Alberta

Not yet recruiting

A Phase II Trial of iTTo in Advanced Gastric and GEJ Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma | Advanced Gastric Carcinoma

Canada
AHS Cancer Control Alberta

Recruiting

Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients

Glioblastoma Multiforme

Canada
AHS Cancer Control Alberta

Recruiting

Pre- Versus Post-operative SRS for Resectable Brain Metastases

Brain Metastases

Canada
AHS Cancer Control Alberta

Recruiting

HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis (ATG2017)

Relapse | Graft-versus-host-disease

Canada
AHS Cancer Control Alberta

Recruiting

A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours

Carcinoma, Neuroendocrine

Canada
AHS Cancer Control Alberta

Terminated

Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate (PREMIUM)

Prostatic Neoplasm

Canada
AHS Cancer Control Alberta

Completed

Multi-Parametric Brain Cancer MRI

Brain Tumors

Canada
SOTIO a.s.

Completed

Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer

Stage IV Non-small Cell Lung Cancer

Czechia, Slovakia
SOTIO a.s.

Completed

DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer

Ovarian Cancer Recurrent

Czechia
AHS Cancer Control Alberta

Completed

A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland (PET PRO)

Prostatic Neoplasms

Canada
Columbia University
ALS Association

Terminated

Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

United States
AHS Cancer Control Alberta

Terminated

Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment

Colon Cancer

Canada
AHS Cancer Control Alberta

Withdrawn

Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib

Fatigue | Renal Cell Cancer

Canada
AHS Cancer Control Alberta

Terminated

Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy (CIPN)

Peripheral Neuropathy in Breast Cancer Patient

Canada
AHS Cancer Control Alberta

Withdrawn

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

Hypoxic Tumours
Emory University
ALS Association

Completed

Immunosuppression in Amyotrophic Lateral Sclerosis (ALS) (NIPALS2013)

Amyotrophic Lateral Sclerosis (ALS)

United States
AHS Cancer Control Alberta

Completed

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours

Lung Neoplasms | Lung Cancer

Canada
AHS Cancer Control Alberta

Unknown

A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely

Neoplasm Metastasis | Colonic Neoplasms
AHS Cancer Control Alberta

Unknown

Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients (CHIRP)

High-risk Prostate Cancer

Canada
AHS Cancer Control Alberta

Completed

Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer

Breast Cancer

Canada
AHS Cancer Control Alberta

Unknown

Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology

Glioma

Canada
AHS Cancer Control Alberta

Completed

Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers

Prostate Cancer

Canada
AHS Cancer Control Alberta

Completed

The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors

Colonic Neoplasms

Canada
AHS Cancer Control Alberta

Completed

Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

Glioma

Canada
AHS Cancer Control Alberta

Terminated

Blood Test to Measure DNA Damage in Blood

Prostate Cancer

Canada
AHS Cancer Control Alberta

Terminated

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

Gastric Cancer | Esophageal Cancer | Tumors

Canada
AHS Cancer Control Alberta

Unknown

Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone

Bone Scan

Canada
AHS Cancer Control Alberta

Unknown

Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components

Glioma

Canada
AHS Cancer Control Alberta

Completed

Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients

Seminoma | Testicular Cancer | Non-seminomatous

Canada
AHS Cancer Control Alberta

Terminated

Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

Metastatic Breast Cancer

Canada

3

Subscribe